{"id":36510,"date":"2015-06-30T09:59:48","date_gmt":"2015-06-30T13:59:48","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=36510"},"modified":"2015-06-30T09:59:48","modified_gmt":"2015-06-30T13:59:48","slug":"impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510","title":{"rendered":"Impact Of Billion Dollar Deal Between Celgene Corporation (NASDAQ:CELG) And Juno Therapeutics Inc (NASDAQ:JUNO) On Biotech Market"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Celgene Corporation (NASDAQ:CELG)<\/strong> announced yesterday that it will spend roughly $1 billion to venture into a partnership with <strong>Juno Therapeutics Inc (NASDAQ:JUNO).<\/strong><\/p>\n<p style=\"text-align: justify;\">The two firms will engage in a ten-year partnership that is expected to keep the biotech bull market going. Celgene maintains that the deal is in the best interest of the company, regardless of the increasing claims that the company is trying to lock up Juno\u2019s technology during its development phase. A large percentage of the $1 billion will be used to purchase roughly 9.1 million Juno shares at $93 per share. The share price is almost double Juno\u2019s closing price on Monday.<\/p>\n<p style=\"text-align: justify;\">Juno is a promising biotech firm based in Seattle. The company went public in December 2014. Its IPO was ranked as one of the largest in the biotech division. Juno was described as one of the most promising biotech companies because of its involvement in the genetically engineered immune cells. The cells can identify and attack tumors, thus promising a bright future for cancer treatment.<\/p>\n<p style=\"text-align: justify;\">Celgene is one of the major players in the biotechnology industry. The partnership will offer strategic benefits to Juno. It will boost Juno\u2019s competitive advantage against its competitors such as <strong>Novartis AG (ADR) (NYSE:NVS).<\/strong>The latter is also developing similar tumor treatments. Analysts view the partnership as a better option compared to an acquisition. This is because Celgene would have spent too much time in the transaction processes, thus being distracted from operations. The Juno IPO was significant in reviving the biotech IPO market.<\/p>\n<p style=\"text-align: justify;\">Juno\u2019s Chief Executive Hans Bishop pointed out that Celgene Corporation (NASDAQ:CELG) is the perfect partner for Juno to achieve the full capacity of its science and clinical research. He stated that maintaining corporate independence is vital for the firm to achieve true innovation.However, not everyone thinks that the current strategy will be a smooth sail. Geoffrey Porges from Sanford C. Bernstein &amp; Company feels that the strategy is risky, considering the past drug development failures. Despite his fears, he commended the Celgene\u2019s management on their audacious feat.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Celgene Corporation (NASDAQ:CELG) announced yesterday that it will spend roughly $1 billion to venture into a partnership with Juno Therapeutics Inc (NASDAQ:JUNO). The two firms [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":20480,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[2860,11579,11266,2861,11267,1740,1464],"stock_ticker":[],"class_list":["post-36510","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-celgene-corporation-nasdaqcelg","tag-hans-bishop","tag-juno-therapeutics-inc-nasdaqjuno","tag-nasdaqcelg","tag-nasdaqjuno","tag-novartis-ag-adr-nysenvs","tag-nysenvs","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Impact Of Billion Dollar Deal Between Celgene Corporation (NASDAQ:CELG) And Juno Therapeutics Inc (NASDAQ:JUNO) On Biotech Market - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Impact Of Billion Dollar Deal Between Celgene Corporation (NASDAQ:CELG) And Juno Therapeutics Inc (NASDAQ:JUNO) On Biotech Market - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Celgene Corporation (NASDAQ:CELG) announced yesterday that it will spend roughly $1 billion to venture into a partnership with Juno Therapeutics Inc (NASDAQ:JUNO). The two firms [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-06-30T13:59:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/celgene-corporation1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"870\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Impact Of Billion Dollar Deal Between Celgene Corporation (NASDAQ:CELG) And Juno Therapeutics Inc (NASDAQ:JUNO) On Biotech Market\",\"datePublished\":\"2015-06-30T13:59:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510\"},\"wordCount\":365,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/celgene-corporation1.jpg\",\"keywords\":[\"Celgene Corporation (NASDAQ:CELG)\",\"Hans Bishop\",\"Juno Therapeutics Inc (NASDAQ:JUNO)\",\"NASDAQ:CELG\",\"NASDAQ:JUNO\",\"Novartis AG (ADR) (NYSE:NVS)\",\"NYSE:NVS\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510\",\"name\":\"Impact Of Billion Dollar Deal Between Celgene Corporation (NASDAQ:CELG) And Juno Therapeutics Inc (NASDAQ:JUNO) On Biotech Market - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/celgene-corporation1.jpg\",\"datePublished\":\"2015-06-30T13:59:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/celgene-corporation1.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/celgene-corporation1.jpg\",\"width\":870,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Impact Of Billion Dollar Deal Between Celgene Corporation (NASDAQ:CELG) And Juno Therapeutics Inc (NASDAQ:JUNO) On Biotech Market\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Impact Of Billion Dollar Deal Between Celgene Corporation (NASDAQ:CELG) And Juno Therapeutics Inc (NASDAQ:JUNO) On Biotech Market - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510","og_locale":"en_US","og_type":"article","og_title":"Impact Of Billion Dollar Deal Between Celgene Corporation (NASDAQ:CELG) And Juno Therapeutics Inc (NASDAQ:JUNO) On Biotech Market - Wall Street PR","og_description":"Celgene Corporation (NASDAQ:CELG) announced yesterday that it will spend roughly $1 billion to venture into a partnership with Juno Therapeutics Inc (NASDAQ:JUNO). The two firms [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2015-06-30T13:59:48+00:00","og_image":[{"width":870,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/celgene-corporation1.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Impact Of Billion Dollar Deal Between Celgene Corporation (NASDAQ:CELG) And Juno Therapeutics Inc (NASDAQ:JUNO) On Biotech Market","datePublished":"2015-06-30T13:59:48+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510"},"wordCount":365,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/celgene-corporation1.jpg","keywords":["Celgene Corporation (NASDAQ:CELG)","Hans Bishop","Juno Therapeutics Inc (NASDAQ:JUNO)","NASDAQ:CELG","NASDAQ:JUNO","Novartis AG (ADR) (NYSE:NVS)","NYSE:NVS"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510","url":"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510","name":"Impact Of Billion Dollar Deal Between Celgene Corporation (NASDAQ:CELG) And Juno Therapeutics Inc (NASDAQ:JUNO) On Biotech Market - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/celgene-corporation1.jpg","datePublished":"2015-06-30T13:59:48+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/celgene-corporation1.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/celgene-corporation1.jpg","width":870,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/impact-of-billion-dollar-deal-between-celgene-corporation-nasdaqcelg-and-juno-therapeutics-inc-nasdaqjuno-on-biotech-market-36510#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Impact Of Billion Dollar Deal Between Celgene Corporation (NASDAQ:CELG) And Juno Therapeutics Inc (NASDAQ:JUNO) On Biotech Market"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36510","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=36510"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/36510\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/20480"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=36510"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=36510"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=36510"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=36510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}